These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 38247541)

  • 1. Oxidative Stress, Inflammation, and Mitochondrial Dysfunction: A Link between Obesity and Atrial Fibrillation.
    Balan AI; Halațiu VB; Scridon A
    Antioxidants (Basel); 2024 Jan; 13(1):. PubMed ID: 38247541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmogenic Substrates for Atrial Fibrillation in Obesity.
    Lubbers ER; Price MV; Mohler PJ
    Front Physiol; 2018; 9():1482. PubMed ID: 30405438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation, a link between obesity and atrial fibrillation.
    Scridon A; Dobreanu D; Chevalier P; Şerban RC
    Inflamm Res; 2015 Jun; 64(6):383-93. PubMed ID: 25929437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance.
    Shu H; Cheng J; Li N; Zhang Z; Nie J; Peng Y; Wang Y; Wang DW; Zhou N
    Cardiovasc Diabetol; 2023 Jul; 22(1):192. PubMed ID: 37516824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing Fatty Acids Oxidation
    Zhang Y; Fu Y; Jiang T; Liu B; Sun H; Zhang Y; Fan B; Li X; Qin X; Zheng Q
    Front Pharmacol; 2021; 12():771940. PubMed ID: 34899326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction as an arrhythmogenic substrate: a translational proof-of-concept study in patients with metabolic syndrome in whom post-operative atrial fibrillation develops.
    Montaigne D; Marechal X; Lefebvre P; Modine T; Fayad G; Dehondt H; Hurt C; Coisne A; Koussa M; Remy-Jouet I; Zerimech F; Boulanger E; Lacroix D; Staels B; Neviere R
    J Am Coll Cardiol; 2013 Oct; 62(16):1466-73. PubMed ID: 23644086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and atrial fibrillation: A comprehensive review of the pathophysiological mechanisms and links.
    Goudis CA; Korantzopoulos P; Ntalas IV; Kallergis EM; Ketikoglou DG
    J Cardiol; 2015 Nov; 66(5):361-9. PubMed ID: 25959929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation.
    Aguilar M; Rose RA; Takawale A; Nattel S; Reilly S
    Cardiovasc Res; 2021 Jun; 117(7):1645-1661. PubMed ID: 33723575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Overview of Obesity and Diabetes Mellitus as Risk Factors for Atrial Fibrillation and Sudden Cardiac Death.
    Homan EA; Reyes MV; Hickey KT; Morrow JP
    Front Physiol; 2018; 9():1847. PubMed ID: 30666210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion Channel and Structural Remodeling in Obesity-Mediated Atrial Fibrillation.
    McCauley MD; Hong L; Sridhar A; Menon A; Perike S; Zhang M; da Silva IB; Yan J; Bonini MG; Ai X; Rehman J; Darbar D
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008296. PubMed ID: 32654503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue.
    Packer M
    Cardiovasc Diabetol; 2019 Sep; 18(1):121. PubMed ID: 31551089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review.
    Menezes Júnior ADS; França-E-Silva ALG; Oliveira JM; Silva DMD
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes.
    Karam BS; Chavez-Moreno A; Koh W; Akar JG; Akar FG
    Cardiovasc Diabetol; 2017 Sep; 16(1):120. PubMed ID: 28962617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity-Related Atrial Fibrillation: Cardiac Manifestation of a Systemic Disease.
    Limpitikul WB; Das S
    J Cardiovasc Dev Dis; 2023 Jul; 10(8):. PubMed ID: 37623336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and Metabolic Syndrome in Atrial Fibrillation: Cardiac and Noncardiac Adipose Tissue in Atrial Fibrillation.
    Mahajan R; Wong CX
    Card Electrophysiol Clin; 2021 Mar; 13(1):77-86. PubMed ID: 33516409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and atrial fibrillation.
    Abed HS; Wittert GA
    Obes Rev; 2013 Nov; 14(11):929-38. PubMed ID: 23879190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Cardiovascular and Metabolic Comorbidities in the Link between Atrial Fibrillation and Cognitive Impairment: An Appraisal of Current Scientific Evidence.
    AlTurki A; Maj JB; Marafi M; Donato F; Vescovo G; Russo V; Proietti R
    Medicina (Kaunas); 2019 Nov; 55(12):. PubMed ID: 31801224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of interleukins in pathogenesis and prognosis of atrial fibrillation.
    Lotfi ME; Pezeshki PS; Rezaei N
    Expert Rev Clin Immunol; 2023 Jun; 19(6):585-597. PubMed ID: 36964672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feeding the critically ill obese patient: a systematic review protocol.
    Secombe P; Harley S; Chapman M; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and Atrial Fibrillation: A Narrative Review.
    Gupta V; Munjal JS; Jhajj P; Jhajj S; Jain R
    Cureus; 2022 Nov; 14(11):e31205. PubMed ID: 36505155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.